[go: up one dir, main page]

GB201502156D0 - Pharmaceutical compound - Google Patents

Pharmaceutical compound

Info

Publication number
GB201502156D0
GB201502156D0 GB201502156A GB201502156A GB201502156D0 GB 201502156 D0 GB201502156 D0 GB 201502156D0 GB 201502156 A GB201502156 A GB 201502156A GB 201502156 A GB201502156 A GB 201502156A GB 201502156 D0 GB201502156 D0 GB 201502156D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical compound
pharmaceutical
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB201502156A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Iomet Pharma Ltd
Original Assignee
Iomet Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Iomet Pharma Ltd filed Critical Iomet Pharma Ltd
Priority to GB201502156A priority Critical patent/GB201502156D0/en
Priority to GEAP201514317A priority patent/GEP20217247B/en
Priority to BR112016022785A priority patent/BR112016022785B8/en
Priority to MA39840A priority patent/MA39840B1/en
Priority to LTEP15710533.9T priority patent/LT3125883T/en
Priority to KR1020167030585A priority patent/KR20160140892A/en
Priority to CR20160514A priority patent/CR20160514A/en
Priority to PCT/EP2015/055823 priority patent/WO2015150097A1/en
Priority to RS20201190A priority patent/RS60878B1/en
Priority to SI201531398T priority patent/SI3125883T1/en
Priority to CA2944240A priority patent/CA2944240A1/en
Priority to AP2016009517A priority patent/AP2016009517A0/en
Priority to EA201692010A priority patent/EA032760B1/en
Priority to NZ725860A priority patent/NZ725860A/en
Priority to ES15710533T priority patent/ES2823825T3/en
Priority to CN201580030284.1A priority patent/CN106715417B/en
Priority to HUE15710533A priority patent/HUE052099T2/en
Priority to AU2015239886A priority patent/AU2015239886B2/en
Priority to EP15710533.9A priority patent/EP3125883B1/en
Priority to US15/301,619 priority patent/US10167257B2/en
Priority to DK15710533.9T priority patent/DK3125883T3/en
Priority to PT157105339T priority patent/PT3125883T/en
Priority to JP2016560772A priority patent/JP6554117B2/en
Priority to UAA201611040A priority patent/UA121386C2/en
Priority to MX2016012984A priority patent/MX385158B/en
Priority to HRP20201621TT priority patent/HRP20201621T1/en
Priority to PL15710533T priority patent/PL3125883T3/en
Publication of GB201502156D0 publication Critical patent/GB201502156D0/en
Priority to JP2016233718A priority patent/JP6134046B1/en
Priority to CY20201100979T priority patent/CY1123548T1/en
Ceased legal-status Critical Current

Links

GB201502156A 2014-04-04 2015-02-10 Pharmaceutical compound Ceased GB201502156D0 (en)

Priority Applications (29)

Application Number Priority Date Filing Date Title
GB201502156A GB201502156D0 (en) 2015-02-10 2015-02-10 Pharmaceutical compound
HUE15710533A HUE052099T2 (en) 2014-04-04 2015-03-19 Indole derivatives for use in medicine
CN201580030284.1A CN106715417B (en) 2014-04-04 2015-03-19 Indole derivatives for use in medicine
MA39840A MA39840B1 (en) 2014-04-04 2015-03-19 Indolated derivatives intended for use in the field of medicine
LTEP15710533.9T LT3125883T (en) 2014-04-04 2015-03-19 Indole derivatives for use in medicine
KR1020167030585A KR20160140892A (en) 2014-04-04 2015-03-19 Indole derivatives for use in medicine
CR20160514A CR20160514A (en) 2014-04-04 2015-03-19 INDOL DERIVATIVES FOR USE IN MEDICINE
PCT/EP2015/055823 WO2015150097A1 (en) 2014-04-04 2015-03-19 Indole derivatives for use in medicine
RS20201190A RS60878B1 (en) 2014-04-04 2015-03-19 Indole derivatives for use in medicine
SI201531398T SI3125883T1 (en) 2014-04-04 2015-03-19 Indole derivatives for use in medicine
CA2944240A CA2944240A1 (en) 2014-04-04 2015-03-19 Indole derivatives as ido/tdo inhibitors
AP2016009517A AP2016009517A0 (en) 2015-02-10 2015-03-19 Indole derivatives for use in medicine
EA201692010A EA032760B1 (en) 2014-04-04 2015-03-19 Ido and tdo inhibitor compounds
NZ725860A NZ725860A (en) 2014-04-04 2015-03-19 Indole derivatives for use in medicine
ES15710533T ES2823825T3 (en) 2014-04-04 2015-03-19 Indole derivatives for use in medicine
GEAP201514317A GEP20217247B (en) 2014-04-04 2015-03-19 Indole derivatives for use in medicine
PT157105339T PT3125883T (en) 2014-04-04 2015-03-19 Indole derivatives for use in medicine
UAA201611040A UA121386C2 (en) 2014-04-04 2015-03-19 INDOLA DERIVATIVES, PHARMACEUTICAL COMPOSITION, WHICH CONTAINS THEM, AND METHODS OF THEIR APPLICATION
EP15710533.9A EP3125883B1 (en) 2014-04-04 2015-03-19 Indole derivatives for use in medicine
US15/301,619 US10167257B2 (en) 2014-04-04 2015-03-19 Indole derivatives for use in medicine
DK15710533.9T DK3125883T3 (en) 2014-04-04 2015-03-19 CONTENTS DERIVATIVES FOR USE IN MEDICINE
BR112016022785A BR112016022785B8 (en) 2014-04-04 2015-03-19 tryptophan-2,3-dioxigenase (tdo) and / or indoleamine-2,3-dioxigenase (acid) inhibitor compound, pharmaceutical composition, and use of tryptophan-2,3-dioxigenase (tdo) inhibitor and / or indoleamine-2,3dioxigenase (acid) or a pharmaceutically acceptable salt thereof for the manufacture of a medicinal product
JP2016560772A JP6554117B2 (en) 2014-04-04 2015-03-19 Indole derivatives used in medicine
AU2015239886A AU2015239886B2 (en) 2014-04-04 2015-03-19 Indole derivatives for use in medicine
MX2016012984A MX385158B (en) 2014-04-04 2015-03-19 INDOL DERIVATIVES FOR USE IN MEDICINE.
HRP20201621TT HRP20201621T1 (en) 2014-04-04 2015-03-19 Indole derivatives for use in medicine
PL15710533T PL3125883T3 (en) 2014-04-04 2015-03-19 Indole derivatives for use in medicine
JP2016233718A JP6134046B1 (en) 2014-04-04 2016-12-01 Indole derivatives used in medicine
CY20201100979T CY1123548T1 (en) 2014-04-04 2020-10-15 INDOLE DERIVATIVES FOR MEDICAL USE

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB201502156A GB201502156D0 (en) 2015-02-10 2015-02-10 Pharmaceutical compound

Publications (1)

Publication Number Publication Date
GB201502156D0 true GB201502156D0 (en) 2015-03-25

Family

ID=52746379

Family Applications (1)

Application Number Title Priority Date Filing Date
GB201502156A Ceased GB201502156D0 (en) 2014-04-04 2015-02-10 Pharmaceutical compound

Country Status (2)

Country Link
AP (1) AP2016009517A0 (en)
GB (1) GB201502156D0 (en)

Also Published As

Publication number Publication date
AP2016009517A0 (en) 2016-10-31

Similar Documents

Publication Publication Date Title
IL266017A (en) Pharmaceutical compounds
IL258213B (en) Pharmaceutical compounds
GB201511790D0 (en) Pharmaceutical compound
GB201419579D0 (en) Pharmaceutical compound
GB201414730D0 (en) Pharmaceutical compound
GB201504675D0 (en) Pharmaceutical compounds
GB201612092D0 (en) Pharmaceutical compounds
GB201506658D0 (en) Pharmaceutical compounds
ZA201900540B (en) Pharmaceutical compounds
GB201617758D0 (en) Pharmaceutical compounds
GB201519352D0 (en) Pharmaceutical compounds
GB201506660D0 (en) Pharmaceutical compounds
IL258246A (en) Pharmaceutical compounds
GB201617454D0 (en) Pharmaceutical compounds
GB201617627D0 (en) Pharmaceutical compounds
GB201612095D0 (en) Pharmaceutical compounds
GB201516411D0 (en) Pharmaceutical compound
GB201506933D0 (en) Pharmaceutical compounds
GB201502567D0 (en) Pharmaceutical compounds
SG11201708818VA (en) Pharmaceutical compound
GB201617871D0 (en) Pharmaceutical compounds
SG11201708817XA (en) Pharmaceutical compound
GB201615916D0 (en) Pharmaceutical compound
GB201615912D0 (en) Pharmaceutical compound
GB201507883D0 (en) Pharmaceutical compound

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)